Logo

American Heart Association

  103
  0


Final ID: MDP1523

Prevalence, Clinical Correlates, and Outcomes of Tricuspid Regurgitation Among Older Adults: The Atherosclerosis Risk in Communities Study

Abstract Body (Do not enter title and authors here): Introduction: Tricuspid regurgitation (TR) prevalence increases with age and is associated with higher mortality. Limited data exist regarding the prognostic relevance of TR among older adults in the general population.

Objective: To estimate the prevalence of TR in late life, identify cardiac structural and functional measures associated with TR severity, and determine the prognostic relevance of TR severity.

Methods: In the community-based Atherosclerosis Risk in Communities (ARIC) study, 3,046 participants underwent protocol echocardiography at the 7th study visit (2018-2019). TR severity was assessed qualitatively as none/trace, mild, moderate, or severe by a board-certified cardiologist. Dyspnea was assessed using the modified Medical Research Council questionnaire and post-Visit 7 mortality was ascertained through the National Death Index. Cross-sectional associations of TR severity with clinical characteristics, echocardiographic measures, and dyspnea were assessed using multivariable linear and logistic regression models. Associations with death were assessed using Cox proportional hazard models adjusted for demographics.

Results: Mean age was 81±4 years, 58% were women, 25% reported Black race, and mean LVEF was 63±8%. TR prevalence was 30% mild, 9% moderate, and 1% severe. Greater TR severity was associated with older age, female sex, higher HF prevalence, and loop diuretic use. Greater TR severity was also associated with lower LVEF, worse LV diastolic function (higher LAVi, E/A, E/e’ septal), higher NT-proBNP, higher prevalence of moderate-severe mitral regurgitation, greater pulmonary artery systolic pressure, and larger RV size. Severe TR was associated with higher odds of moderate-severe dyspnea (OR:2.3 [1.2-4.5], p=0.012). During follow-up (median 2.1 years [IQR 1.7-2.5]), 192 participants died. Higher TR severity was associated with greater mortality (Figure). Compared to participants with none/trace TR, even mild TR was associated with a 64% greater mortality risk.

Conclusion: TR is common in late life and is associated with greater left heart disease despite generally preserved LVEF. Greater TR severity, even when mild, is a marker of increased mortality. Longer follow-up is needed to determine whether this risk is independent of concomitant left heart dysfunction.
  • Kharidia, Khush  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Shah, Amil  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Giugni, Fernando  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Lamberson, Victoria  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Yang, Yimin  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Claggett, Brian  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Van't Hof, Jeremy  ( University of Minnesota , Minneapolis , Minnesota , United States )
  • Wagenknecht, Lynne  ( Wake Forest University , Winston-Salem , North Carolina , United States )
  • Mosley, Thomas  ( UNIV MS MEDICAL CTR , Jackson , Mississippi , United States )
  • Skali, Hicham  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Khush Kharidia: DO NOT have relevant financial relationships | Amil Shah: DO have relevant financial relationships ; Advisor:Philips Ultrasound:Past (completed) ; Advisor:Janssen:Past (completed) | Fernando Giugni: DO NOT have relevant financial relationships | Victoria Lamberson: DO NOT have relevant financial relationships | Yimin Yang: DO NOT have relevant financial relationships | Brian Claggett: DO have relevant financial relationships ; Consultant:Cardior:Active (exists now) ; Consultant:Eli Lilly:Active (exists now) ; Consultant:CVRx:Past (completed) ; Consultant:Intellia:Active (exists now) ; Consultant:Cytokinetics:Past (completed) ; Consultant:Cardurion:Active (exists now) | Jeremy Van't Hof: DO NOT have relevant financial relationships | Lynne Wagenknecht: No Answer | Thomas Mosley: DO NOT have relevant financial relationships | Hicham Skali: DO have relevant financial relationships ; Research Funding (PI or named investigator):Cytokinetics:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:
More abstracts on this topic:
Association of Moderate-Severe Tricuspid Regurgitation with Exercise Hemodynamics and Outcomes in Patients in Heart Failure with Preserved Ejection Fraction: Multicenter Study

Dorsey Natalie, Caravita Sergio, Tedford Ryan, Rao Vishal N., Baratto Claudia, Biscopink Alec, Taylor Eric, Atkins Jessica, Amoroso Nicholas, Carnicelli Anthony, Houston Brian, Silkowski Molly

Hydatid Cyst in the Right Ventricle leading to Tricuspid stenosis and Heart Failure– A Case Report

Hameed Muhammad Sheraz, Naveed Muhammad Usama, Fatima Rida, Masood Hania, Shah Syed Saqib Ali, Zaidi Syed Rafay, Iqbal Ali, Javaid Muhammad Umer, Hassan Muhammad Hammad Ul

More abstracts from these authors:
Association of circulating senescence-associated secretory phenotype (SASP) proteins with the development of frailty in late-life: the Atherosclerosis Risk in Communities (ARIC) Study

Yang Yimin, Mosley Thomas, Sharrett A, Palta Priya, Windham B Gwen, Shah Amil, Giugni Fernando, Dehghan Arshama, Lamberson Victoria, Claggett Brian, Yu Bing, Fornage Myriam, Giannarelli Chiara, Grams Morgan

Large-Scale Proteomics Identifies Novel Circulating Markers of Pulmonary Hypertension: the Atherosclerosis Risk in Communities Study

Giugni Fernando, Santos Mario, Yang Yimin, Lamberson Victoria, Claggett Brian, Hoogeveen Ron, Ballantyne Christie, Yu Bing, Shah Amil

You have to be authorized to contact abstract author. Please, Login
Not Available